Electronic Data
Capture Software
Market Intelligence
9CV9 Research Report · 2026 Edition
A comprehensive data-driven analysis of the global EDC software landscape — market sizing, growth drivers, technology trends, and competitive dynamics shaping the industry in 2026 and beyond.
$2.71B
Global Market 2026
15.8%
CAGR 2025–2026
$4.47B
Projected by 2030
51%
N. America Share
Market Size & Growth Trajectory
Global Market 2025
$2.34B
Global EDC systems market valuation in 2025, up from $2.02B in 2024 — a 16.1% single-year jump
Market 2026
$2.71B
Projected 2026 market size, reflecting accelerating digitisation of clinical trial operations worldwide
Horizon 2030
$4.47B
EDC market expected to reach $4.47B by 2030 at a sustained 13.3% CAGR over the forecast window
Long-Term 2034
$5.88B
Precedence Research projects global EDC systems market at $5.88B by 2034 at 13.21% CAGR
EDC Segment (eClinical)
$2.5B
EDC dominated the eClinical solutions space with a $2.5B valuation in 2024 — the largest segment
US Market 2025
$1.3B
US EDC market estimated at $1.3B in 2025, growing to $2.0B by 2033 at ~6.2% CAGR
Regional Market Dominance
Fastest-Growing Region
Asia-Pacific
APAC leads growth with highest CAGR driven by CRO outsourcing, digital trial adoption, and large patient pools across China, India, Japan & South Korea
US Market by 2034
$2.36B
US EDC market projected at $2.36B by 2034, growing at 13.25% CAGR — FDA electronic submission mandates accelerating adoption
Deployment Models & End-User Segments
Web-Hosted Dominance 2024
52.9%
Web-hosted segment held 52.9% of the EDC market in 2024 — preferred for cost-efficiency & multi-site accessibility
Cloud SaaS Share 2026
72.3%
SaaS/cloud-based EDC deployments projected to capture 72.3% market share in 2026 as sponsors migrate from on-premise systems
CRO End-User Share 2024
36%
Contract Research Organizations (CROs) held the dominant end-user share of ~36% in 2024, driven by outsourcing trends
Phase III Dominance
51%
Phase III clinical trials account for 51% of EDC system revenue — large patient bases demand robust data capture platforms
Phase I Growth
Fastest
Phase I segment is the fastest-growing, fuelled by surging early-stage oncology, rare disease, and gene therapy research globally
Pharma/Biotech Share 2024
Largest
Pharma & biopharmaceutical companies held the largest end-user market share in 2024 within eClinical solutions
ROI, Cost Savings & Operational Efficiency
55%
Studies show EDC systems reduce data collection costs by up to 55% compared to traditional paper-based methods — primarily driven by lower error and query rates that shrink data-cleaning workloads. (Source: ScienceDirect / Octalsoft)
20%
Reduction in clinical trial timelines with EDC adoption
50%
Time saved in EHR-to-EDC data entry vs. manual processes
66%
Reduction in manual queries achieved with modern EDC platforms
83%
Faster clinical trial setup versus traditional EDC configurations
Query Resolution Speed
15 Min
EDC resolves data queries in ~15 minutes vs. 5–8 days for paper-based DCF methods — an 800x improvement in speed
Database Lock Acceleration
24 Days
Sponsors and CROs using Medrio EDC cut database lock time by 24 days — critical for faster regulatory submission
AI, Decentralization & Technology Trends
AI in Clinical Trials 2026
$5.5B
AI in clinical trials market reaches $5.5B in 2026, projected to explode to $120.91B by 2034 at 47.14% CAGR
Decentralized Trials 2025
$9.1B
Decentralized clinical trials market valued at $9.1B in 2025, projected to reach $21.4B by 2032 — EDC is the digital backbone
DCT Growth Rate
13.0%
Decentralized clinical trials will grow at 13.0% CAGR from 2026–2032, amplifying demand for cloud-native EDC platforms
Veeva Vault EDC Milestone
1,000+
Veeva Vault EDC surpassed 1,000 study starts by March 2024, with multiple top biopharma & CROs standardising on it
FDA AI Medical Devices 2025
295
FDA cleared 295 AI/ML-enabled medical devices in 2025, reinforcing digital infrastructure needs in clinical research
Clinical Trials Per Year (US)
300K
An estimated 300,000 clinical trials conducted annually in the US alone — each increasingly reliant on EDC systems
Data Quality, Compliance & Risk Metrics
Medrio Customer Retention
98%
Medrio reports a 98% customer retention rate — reflecting the high switching costs and stickiness of EDC platforms
Phase III Data Points Per Patient
10,000
Typical Phase III oncology trials collect ~10,000 data points per patient; genomic trials can multiply this 10–100x
Market Size Forecast Timeline
2024
EDC Systems Market
$2.02B
2025
EDC Systems Market
$2.34B
2026
EDC Systems Market
$2.71B
2030
EDC Systems Market
$4.47B
2034
EDC Systems Market
$5.88B
13.21%
CAGR 2025–2034 (Precedence Research)
15.8%
CAGR 2025–2026 single-year growth rate
16.1%
CAGR 2024–2025 (Business Research Co.)
14.8%
CAGR 2026–2035 (Towards ICT)
$10.14B
EDC market projected by 2035
9.7%
CAGR 2025–2033 (IMARC Group)
Competitive Landscape & Key Developments
Market Leader
Medidata (Dassault)
Rated No. 1 most-used EDC system by Industry Standard Research (Sept 2023); expanded Rave EDC with AI validation in June 2025
Fastest-Rising Player
Veeva Systems
Vault EDC surpassed 1,000+ study starts; acquired European CDM startup in July 2025 to boost interoperability
Enterprise Leader
Oracle Clinical One
Launched Oracle Clinical One Data Collection in August 2025; completed acquisition of AI analytics firm in March 2025
Clinical Trial Software 2026
$1.51B
Clinical trial software market reaches $1.51B in 2026, growing at 14.1% CAGR — complementing the EDC software ecosystem
EDC Software Forecast 2031
$4.06B
The EDC software market (pure-play) is expected to generate $4.06B by 2031 at a 14.5% CAGR per Verified Market Research
eClinical Solutions Market 2033
$29.65B
Broader eClinical solutions market (encompassing EDC, CTMS, ePRO, etc.) projected to reach $29.65B by 2033 at 13.2% CAGR
Sources: Precedence Research, Fortune Business Insights, Business Research Co., Mordor Intelligence, IMARC Group, Verified Market Research, Data Bridge Market Research, Grand View Research, PS Market Research, PMC/NIH, ScienceDirect, Medrio, Octalsoft, Wemedoo · Data as of 2025–2026 · Compiled by 9CV9 Research